TrialJapanese journal of clinical oncology2019

Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.

Takeo Kosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.